MedPath

NKI Therapy Compared to Usual Care of Recurrent Esophagogastric Anastomotic Strictures

Not Applicable
Terminated
Conditions
Esophageal Stricture
Anastomotic Stenosis
Dilation of Esophagus Due to Disease
Interventions
Procedure: NKI followed by EBD
Registration Number
NCT04406428
Lead Sponsor
Radboud University Medical Center
Brief Summary

Rationale: The study hypothesizes that NKI followed by endoscopic bougie dilation therapy will result in an increased dysphagia-free period, a reduction of endoscopic procedures and dysphagia-related quality of life, and lower costs, when compared with the standard endoscopic bougie dilation (EBD) in recurrent esophagogastric anastomotic strictures.

Objective: To evaluate the efficacy and cost-effectiveness of needle-knife incision (NKI) followed by EBD compared to standard EBD in patients with recurrent esophagogastric anastomotic strictures.

Study design: This multicenter study is an randomized controlled trial in which NKI followed by EBD will be compared with standard EBD.

Study population: Patients with recurrent dysphagia (at least 1 and a maximum of 5 previous dilations) due to an anastomotic esophagogastric stricture that requires treatment with repeated endoscopic bougie dilations.

Intervention : The intervention to be investigated is the addition of NKI therapy to EBD to 18 mm esophageal diameter.

Main study parameters/endpoints: The primary outcome of this study will be EBD-free time during follow-up of 6 months. Secondary outcome parameters will be the number of endoscopic procedures for treatment of dysphagia, quality of life (QoL), cost-reduction and cost-effectiveness.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Recurrent intra- or extrathoracic benign esophagogastric anastomotic stricture after esophagectomy. The definition of a stricture is based on the Ogilvie Dysphagia score (severity of dysphagia), i.e. Ogilvie score ≥2 (= ability to swallow semi-solid food or worse (Appendix table 1)).
  • No patency for a standard endoscope (diameter < 10 mm)
  • The recurrent stricture has been previously treated with at least 1 to a maximum of 5 EBD sessions that reached an esophageal diameter of ≥16 mm.
  • The stricture should be suitable for endoscopic incision (stricture length ≤10 mm).
Read More
Exclusion Criteria
  • Benign esophageal stricture other than an esophagogastric anastomotic stricture.
  • Strictures with a morphology unsuitable for NKI, such as long (>1 cm), irregulair or tortuous strictures.
  • Previous endoscopic treatment of the esophageal stricture with steroid injection, incision therapy or stent placement within the past 3 months.
  • Previous stent placement post-esophagectomy for anastomotic leakage.
  • (Suspicion of) locally recurrent or metastasized esophageal cancer.
  • Persisting postoperative esophageal fistula.
  • Inability to discontinue anticoagulants or high-dose antiplatelet drugs at time of the baseline procedure. Low-dose aspirin (max. 100 mg/day) may be continued.
  • Known clotting disorder that cannot pre-procedural be corrected.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NKI followed by EBDNKI followed by EBD-
Primary Outcome Measures
NameTimeMethod
Dilation free time6 months

EBD-free time

Secondary Outcome Measures
NameTimeMethod
Endoscopic procedures6 months

Number of endoscopic procedures for treatment of dysphagia

QoL6 months

Quality of life

Cost-reduction6 months
Cost-effectiveness6 months

Trial Locations

Locations (1)

Radboudumc

🇳🇱

Nijmegen, Gelderland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath